1%w/v & 2%w/v Lidocaine Hydrochloride Injection, USP

1%w/v & 2%w/v Lidocaine Hydrochloride Injection, USP
Product Description

Suppression of ventricular extrasystoles and ventricular tachycardia, especially after an acute myocardial infarction. Local anaesthesia by surface infiltration, regional, epidural and caudal routes, dental anaesthesia, either alone or in combination with adrenaline. Lidocaine may also be administered by subcutaneous, intramuscular or intravenous injection.Not intended for use in the eye.

Read more Show less

Qatar Pharma

  • Country/Region:
    Qatar
  • On CPHI since:
    2019
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    6108-05-0
More specifications Fewer specifications
Sales Markets
Show more Show less

Qatar Pharma

  • Country/Region:
    Qatar
  • On CPHI since:
    2019
View company profile

More Products from Qatar Pharma (2)

  • 0.5%w/v Levofloxacin Injection

    Product 0.5%w/v Levofloxacin Injection

    0.5% w/v Levofloxacin Injection is indicated in adults for the treatment of the following infections : Community-acquired pneumonia, Complicated skin and soft tissue infection. For the above-mentioned infections 0.5% w/v Levofloxacin Injection should be used only when it is considered inappropria...
  • 0.5%w/v Metronidazole Injection USP

    Product 0.5%w/v Metronidazole Injection USP

    0.5%w/v  Metronidazole  Injection  USP  is  indicated  in  adults  and  children  when  oral medication is not possible for the following indications: - The prophylaxis of postoperative infections due to sensitive anaerobic bacteria particularly s...

Qatar Pharma resources (1)